- Home
- BIOA vs MG Comparison
BIOA vs MG Comparison
Compare BIOA & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIOA | MG |
|---|---|---|
| Founded | 2015 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.0M | 531.0M |
| IPO Year | 2024 | 2008 |
Fundamental Metrics
Financial Performance| Metric | BIOA | MG |
|---|---|---|
| Price | $10.46 | $18.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $51.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 172.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.21 | N/A |
| EPS | N/A | ★ 0.30 |
| Revenue | $8,995,000.00 | ★ $700,970,000.00 |
| Revenue This Year | $720.93 | $5.47 |
| Revenue Next Year | N/A | $3.59 |
| P/E Ratio | ★ N/A | $60.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.39 | $8.96 |
| 52 Week High | $25.96 | $19.64 |
Technical Indicators
Market Signals| Indicator | BIOA | MG |
|---|---|---|
| Relative Strength Index (RSI) | 30.99 | 61.79 |
| Support Level | $7.95 | $13.37 |
| Resistance Level | $13.17 | $19.30 |
| Average True Range (ATR) | 1.04 | 0.81 |
| MACD | -0.25 | 0.34 |
| Stochastic Oscillator | 10.27 | 69.11 |
Price Performance
Historical ComparisonAbout BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.